CRISPR Therapeutics AG (NASDAQ: CRSP) shares fell -0.2430% to end trading Tuesday at $118.91 per share - a net change of $-0.29.
Visit CRISPR Therapeutics AG’s profile for more information.
About The Nasdaq Stock Market
The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.
To get more information on CRISPR Therapeutics AG and to follow the company’s latest updates, you can visit the company’s profile page here:
CRISPR Therapeutics AG’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.
Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer